Abstract
| Original language | English |
|---|---|
| Pages (from-to) | 1375 - 1379 |
| Number of pages | 5 |
| Journal | Aids Care: Psychological and Socio-Medical Aspects of AIDS/HIV |
| Volume | 25 |
| Issue number | 11 |
| DOIs | |
| Publication status | Published - 2013 |
Cite this
}
Australian prescribers' perspectives on ART initiation in the era of "treatment as prevention". / Mao, Limin; de Wit, John; Adam, Philippe; Post, Jeffrey; Crooks, Levinia; Kidd, Michael R; Slavin, Sean; Kippax, Susan; Wright, Edwina Jane.
In: Aids Care: Psychological and Socio-Medical Aspects of AIDS/HIV, Vol. 25, No. 11, 2013, p. 1375 - 1379.Research output: Contribution to journal › Article › Research › peer-review
TY - JOUR
T1 - Australian prescribers' perspectives on ART initiation in the era of "treatment as prevention"
AU - Mao, Limin
AU - de Wit, John
AU - Adam, Philippe
AU - Post, Jeffrey
AU - Crooks, Levinia
AU - Kidd, Michael R
AU - Slavin, Sean
AU - Kippax, Susan
AU - Wright, Edwina Jane
PY - 2013
Y1 - 2013
N2 - This study explores Australian prescribers attitudes towards Treatment as Prevention (TasP) and their practices around initiating combination antiretroviral treatment (cART) for HIV. A brief online survey was conducted nationally amongst antiretroviral treatment (ART) prescribers in Australia. The sample broadly represented ART prescribers in Australia (N = 108), with 40.7 general practitioners (GPs), 25.9 sexual health clinic-based physicians and 21.3 hospital-based infectious diseases physicians. About 60 of respondents had been treating HIV-positive patients for more than 10 years. Respondents estimated that about 70-80 of all their HIV-positive patients were receiving ART. Over half of the prescribers agreed very strongly that their primary concern in recommending cART initiation was clinical benefit to individual patients rather than any population benefit. A majority of the prescribers (68.5 ) strongly endorsed cART initiation before CD4+ T-cell count drops below 350 cells/mm3, and a further 22.2 strongly endorsed cART initiation before CD4+ T-cell count drops below 500 cells/mm3. Regarding the optimal timing of cART initiation, this study shows that prescribers in Australia in 2012 focus primarily on the benefits for their individual patients. Prescribers may need more convincing evidence of individual health benefits or increased knowledge about the population health benefits for a TasP approach to be effective in Australia. ? 2013 ? 2013 Taylor Francis.
AB - This study explores Australian prescribers attitudes towards Treatment as Prevention (TasP) and their practices around initiating combination antiretroviral treatment (cART) for HIV. A brief online survey was conducted nationally amongst antiretroviral treatment (ART) prescribers in Australia. The sample broadly represented ART prescribers in Australia (N = 108), with 40.7 general practitioners (GPs), 25.9 sexual health clinic-based physicians and 21.3 hospital-based infectious diseases physicians. About 60 of respondents had been treating HIV-positive patients for more than 10 years. Respondents estimated that about 70-80 of all their HIV-positive patients were receiving ART. Over half of the prescribers agreed very strongly that their primary concern in recommending cART initiation was clinical benefit to individual patients rather than any population benefit. A majority of the prescribers (68.5 ) strongly endorsed cART initiation before CD4+ T-cell count drops below 350 cells/mm3, and a further 22.2 strongly endorsed cART initiation before CD4+ T-cell count drops below 500 cells/mm3. Regarding the optimal timing of cART initiation, this study shows that prescribers in Australia in 2012 focus primarily on the benefits for their individual patients. Prescribers may need more convincing evidence of individual health benefits or increased knowledge about the population health benefits for a TasP approach to be effective in Australia. ? 2013 ? 2013 Taylor Francis.
UR - http://www.ncbi.nlm.nih.gov/pubmed/23406458
U2 - 10.1080/09540121.2013.766304
DO - 10.1080/09540121.2013.766304
M3 - Article
VL - 25
SP - 1375
EP - 1379
JO - Aids Care: Psychological and Socio-Medical Aspects of AIDS/HIV
JF - Aids Care: Psychological and Socio-Medical Aspects of AIDS/HIV
SN - 0954-0121
IS - 11
ER -